0 31/12/2023 2023-12-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2023-01-01 Sage Accounts Production 23.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP NI612590 2023-01-01 2023-12-31 NI612590 2023-12-31 NI612590 2022-12-31 NI612590 2022-01-01 2022-12-31 NI612590 2022-12-31 NI612590 2021-12-31 NI612590 bus:RegisteredOffice 2023-01-01 2023-12-31 NI612590 bus:LeadAgentIfApplicable 2023-01-01 2023-12-31 NI612590 bus:Director1 2023-01-01 2023-12-31 NI612590 core:WithinOneYear 2023-12-31 NI612590 core:WithinOneYear 2022-12-31 NI612590 core:ShareCapital 2023-12-31 NI612590 core:ShareCapital 2022-12-31 NI612590 core:RetainedEarningsAccumulatedLosses 2023-12-31 NI612590 core:RetainedEarningsAccumulatedLosses 2022-12-31 NI612590 bus:Director1 2022-12-31 NI612590 bus:Director1 2023-12-31 NI612590 bus:Director1 2022-12-31 NI612590 bus:Director1 2022-01-01 2022-12-31 NI612590 bus:SmallEntities 2023-01-01 2023-12-31 NI612590 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 NI612590 bus:FullAccounts 2023-01-01 2023-12-31 NI612590 bus:SmallCompaniesRegimeForAccounts 2023-01-01 2023-12-31 NI612590 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31
COMPANY REGISTRATION NUMBER: NI612590
VIROGEN LTD
UNAUDITED FILLETED FINANCIAL STATEMENTS
31 December 2023
Virogen Ltd
Contents
Directors and other information
Accountants report
Statement of financial position
Notes to the financial statements
Virogen Ltd
Directors and other information
Director Mr Daniel Hegarty
Company number NI612590
Registered office ASM (M) Ltd
The Diamond Centre
Market Stree
Magherafelt
BT45 6ED
Accountants PFS Accountants and Auditors Ltd
122 Main Street
Dungiven
Derry
BT47 4LG
Virogen Ltd
Report to the director on the preparation of the
unaudited statutory financial statements of Virogen Ltd
Period ended 31 December 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Virogen Ltd for the period ended 31 December 2023 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Association of Chartered Certified Accountants , we are subject to its ethical and other professional requirements which are detailed at http://www.accaglobal.com/en/member/ professional-standards/ rules-standards/acca-rulebook.html.
This report is made solely to the director of Virogen Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Virogen Ltd and state those matters that we have agreed to state to them, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global /Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Virogen Ltd and its director as a body for our work or for this report.
It is your duty to ensure that Virogen Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Virogen Ltd. You consider that Virogen Ltd is exempt from the statutory audit requirement for the period.
We have not been instructed to carry out an audit or a review of the financial statements of Virogen Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
PFS Accountants and Auditors Ltd
Chartered Certified Accountants
122 Main Street
Dungiven
Derry
BT47 4LG
1 July 2024
Virogen Ltd
Statement of financial position
31 December 2023
31/12/23 31/12/22
Note £ £ £ £
Current assets
Stocks 127,137 62,025
Debtors 4 225,332 207,958
Cash at bank and in hand 247,591 433,326
_______ _______
600,060 703,309
Creditors: amounts falling due
within one year 5 ( 137,453) ( 259,741)
_______ _______
Net current assets 462,607 443,568
_______ _______
Total assets less current liabilities 462,607 443,568
_______ _______
Net assets 462,607 443,568
_______ _______
Capital and reserves
Called up share capital 10 10
Profit and loss account 462,597 443,558
_______ _______
Shareholders funds 462,607 443,568
_______ _______
For the period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 01 July 2024 , and are signed on behalf of the board by:
Mr Daniel Hegarty
Director
Company registration number: NI612590
Virogen Ltd
Notes to the financial statements
Period ended 31 December 2023
1. General information
The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is ASM (M) Ltd, The Diamond Centre, Market Stree, Magherafelt, BT45 6ED.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
4. Debtors
31/12/23 31/12/22
£ £
Trade debtors 181,939 203,639
Other debtors 43,393 4,319
_______ _______
225,332 207,958
_______ _______
5. Creditors: amounts falling due within one year
31/12/23 31/12/22
£ £
Trade creditors 3,522 233,214
Corporation tax 15,575 24,332
Social security and other taxes 8,616 95
Other creditors 109,740 2,100
_______ _______
137,453 259,741
_______ _______
6. Directors advances, credits and guarantees
During the period the director entered into the following advances and credits with the company:
Period ended 31/12/23
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
Mr Daniel Hegarty 4,309 41,000 45,309
_______ _______ _______
Year ended 31/12/22
Balance brought forward Advances /(credits) to the director Balance o/standing
£ £ £
Mr Daniel Hegarty - 4,309 4,309
_______ _______ _______